Rua Bioscience Limited Stock: price and insider trades · New Zealand

Rua Bioscience Limited belongs to the Health Care sector. Filings by its managers are published through NZX. From 25 October 2025 to 25 October 2026, the disclosure feed for Rua Bioscience Limited logged 7 filings by 1 insider.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

There has been no open-market purchase by an insider of Rua Bioscience Limited for at least a year. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public.

For context, the typical company on the same exchange (median of 113 companies) published 8 filings over the same period, against 7 filings here. Over the whole record (from 2020), the tally stands at 2 purchases and 8 sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by NZX. They describe what insiders did and are not a recommendation.